Home Hetero 2904

Hetero 2904

- Advertisement -

APLICATIONS

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

0
VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

HOT NEWS